<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="100902">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02001259</url>
  </required_header>
  <id_info>
    <org_study_id>orthoTU05</org_study_id>
    <nct_id>NCT02001259</nct_id>
  </id_info>
  <brief_title>Efficacy of Epidural Steroid for Controlling Pain After Primary TKA</brief_title>
  <official_title>Efficacy of Epidural Steroid in Controlling Postoperative Pain After Primary Total Knee Arthroplasty: A Randomized Double-blinded Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thammasat University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Thammasat University</source>
  <oversight_info>
    <authority>Thailand: Ethical Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine efficacy of epidural steroid for postoperative
      pain control after TKA
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Epidural triamsinolone can reduce postoperative pain and longer duration of pain control
      after TKA
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>post-operative pain</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured with VAS for pain, drugs for relief pain,</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>functional knee score</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured with WOMAC, EQ5D</description>
  </secondary_outcome>
  <other_outcome>
    <measure>complication of epidural triamsinolone</measure>
    <time_frame>2 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>range of motion of the knee</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Epidural lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>epidural lidocaine: 2 mL of 1% lidocaine with adrenaline and 3 mL of 1% lidocaine without adrenaline into epidural catheter at 48 hr after surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>epidural triamsinolone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>epidural triamsinolone: 40 mg of triamsinolone (1 mL), 2 mL of 1% lidocaine with adrenaline and 2 mL of 1% lidocaine without adrenaline into epidural catheter at 48 hr after surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>epidural triamsinolone</intervention_name>
    <description>add drugs into catheter at 48 hr after surgery</description>
    <arm_group_label>epidural triamsinolone</arm_group_label>
    <other_name>epidural steroid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>epidural lidocaine</intervention_name>
    <description>add into catheter at 48 hr after surgery</description>
    <arm_group_label>Epidural lidocaine</arm_group_label>
    <other_name>epidural xylocaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  osteoarthritis of the knee who undergoing unilateral primary total knee arthroplasty

          -  50-85 years old

          -  ASA class 1-3

        Exclusion Criteria:

          -  unable to perform epidural anaesthesia

          -  history of drug allergies: lidocaine, steroid

          -  renal impairment (CrCl &lt;30 mL/min)

          -  liver impairment

          -  cognitive function disorders

          -  displacement of epidural catheter
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Supakit Kanitnate, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>orthopaedic department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Supakit Kanitnate, M.D.</last_name>
    <phone>6629269775</phone>
    <email>naypeng@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>department of orthopaedic surgery, Faculty of medicine, Thammasat university</name>
      <address>
        <city>Khlong Luang</city>
        <state>Pathumthani</state>
        <zip>066</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>supakit kanitnate</last_name>
      <phone>6629260000</phone>
      <email>naypeng@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Nattapol Tammachote, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Supakit Kanitnate, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 27, 2013</lastchanged_date>
  <firstreceived_date>November 27, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Thammasat University</investigator_affiliation>
    <investigator_full_name>Supakit Kanitnate</investigator_full_name>
    <investigator_title>orthopaedic department</investigator_title>
  </responsible_party>
  <keyword>post-operative pain control</keyword>
  <keyword>total knee arthroplasty</keyword>
  <keyword>epidural steroid injection</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
